rendering of a globe and news stories

PPD in the News

Pharma Tech Outlook (April 2021)

Optimizing clinical trial decision-making

Ravi Ramachandran discusses the need for technologies that accommodate trial participants to obtain a more holistic view of their condition during the clinical research process.

BioPharm International (April 2021)

Stability testing of protein therapeutics using dynamic light scattering

John Bak and Eric Olson explain how dynamic light scattering presents a good analytical technique for testing protein stability.

biopharm logo
Outsourcing-Pharma (April 2021)

PPD, Clinical Ink join on lupus assessment and endpoint data

Carol Olson comments on how the two companies have partnered to develop a systemic lupus erythematosus assessment review to streamline clinical trials.

Outsourcing Pharma Logo
American Pharmaceutical Review (March 2021)

Bacterial endotoxins testing of water-insoluble drug substances by means of dispersion with dimethyl sulfoxide

The authors demonstrate a technique for sample preparation in which the drug substance is dissolved in dimethyl sulfoxide, followed by dilution in water.

American pharmaceutical review logo
Outsourcing-Pharma (March 2021)

US Army taps PPD to conduct PTSD treatment research

PPD receives five-year award to test the effectiveness and safety of pharmacotherapeutic drug candidates for the treatment of PTSD in U.S. military active duty personnel and veterans.

Outsourcing Pharma Logo
Fierce Biotech (March 2021)

PPD pens Clinical Ink collab for new lupus trial platform

The companies jointly developed a systemic lupus erythematosus (SLE) assessment review process to simplify operationalizing clinical trials for the chronic autoimmune disease.

Fierce Biotech
Regulatory Focus (March 2021)

Advantages of developing and deploying an in-house regulatory intelligence

Sean Schofield, William Waggoner and John Joines write about the processes and considerations for developing and maintaining an in-house regulatory intelligence database.

regulatory focus logo
Drug Discovery News (March 2021)

Special report on clinical trials: Delving into decentralization

In this report, Niklas Morton notes how when a fully decentralized trial is not feasible, a hybrid design still offers organizations opportunities to minimize—if not eliminate—burdens on patients.

PharmaVOICE (March 2021)

Decentralized clinical trials: The way forward

Niklas Morton discusses how the industry is considering decentralized trial approaches as a valuable asset in the design and execution of future clinical trials.

PharmaVoice logo